欢迎登录材料期刊网

材料期刊网

高级检索

胶体药物载体的纳米技术是在药学研究中最活跃的领域.综述了其主要特点、类型和表面修饰等问题,并提出了该领域值得注意的若干问题.

参考文献

[1] 邹立家.药剂学[M].北京:中国医药科技出版社,1996
[2] 平其能.现代药剂学[M].北京:中国医药科技出版社,1998
[3] 修志龙;齐冬建;苏志国 .纳米技术在药物制剂中的应用[J].高技术通讯,1996,6(09):56.
[4] Sahoo SK;Labhasetwar V .Nanotech approaches to drug delivery and imaging.[J].Drug discovery today,2003(24):1112-1120.
[5] arrattGM .Therapeutic applications of colloidal drug carriers[J].Pharmaceutical Science & Technology Today,2000,3(05):163.
[6] Davis SS .Biomedical applications of nanotechnology--implications for drug targeting and gene therapy.[J].Trends in Biotechnology,1997(6):217-224.
[7] Soppimath KS.;Kulkarni AR.;Rudzinski WE.;Aminabhavi TM. .Biodegradable polymeric nanoparticles as drug delivery devices [Review][J].Journal of Controlled Release: Official Journal of the Controlled Release Society,2001(1/2):1-20.
[8] CrommelinDJA;Daemen T;Scherphof G L et al.Liposomes: vehicles for the targeted and controlled delivery of peptides and proteins[J].Journal of Controlled Release,1997,46:165.
[9] Lowe CR. .Nanobiotechnology: the fabrication and applications of chemical and biological nanostructures[J].Current Opinion in Structural Biology,2000(4):428-434.
[10] ertramG;Katzung;张殿增.基础与临床药理学[M].北京:世界知识出版社,2000
[11] 修志龙;齐冬建;苏志国 .纳米技术在药物制剂中的应用[J].高技术通讯,1996,9:56.
[12] Kawashima Y;Takeuchi H;Fujioka S;Hino T;Yamamoto H .Pulmonary delivery of insulin with nebulized DL-lactide/glycolide copolymer (PLGA) nanospheres to prolong hypoglycemic effect.[J].Journal of Controlled Release: Official Journal of the Controlled Release Society,1999(1/2):279-287.
[13] Torres Lugo-M;Peppas NA .Transmucosal delivery systems for calcitonin: a review.[J].Biomaterials,2000(12):1191-1196.
[14] 徐辉碧,杨祥良,谢长生,杨亚江.纳米技术在中药研究中的应用[J].中国药科大学学报,2001(03):161-165.
[15] Jain TK.;De TK.;Maitra A.;Roy I. .Nanometer silica particles encapsulating active compounds: A novel ceramic drug carrier[J].Journal of the American Chemical Society,1998(43):11092-11095.
[16] randrissS;Borchardt G;Kreuter J et al.Radiolabled 75Se-silica nanoparticles: synthesis, characterization and coating with ω-functionalized alkylsilane compounds[J].Reactive Polymers,1995,25:111.
[17] Chen JF;Ding HM;Wang JX;Shao L .Preparation and characterization of porous hollow silica nanoparticles for drug delivery application.[J].Biomaterials,2004(4):723-727.
[18] 全从娟,傅正义,马培燕,苏艳丽.纳米技术在中药开发中的应用[J].材料科学与工程学报,2003(04):582-585.
[19] Westesen K. .Novel lipid-based colloidal dispersions as potential drug administration systems-expectations and reality[J].Colloid and polymer science,2000(7):608-618.
[20] 张灵芝.脂质体制备及其在生物医学中的应用[M].北京:北京医科大学中国协和医科大学联合出版社,1998
[21] 顾学裘.抗癌药物靶向载体:中国多相脂质体研究[M].北京:中国医药科技出版社,1991
[22] 袁仕善;周智广 .阳离子脂质体与基因转移[J].生理科学进展,1997,28(02):163.
[23] MehnertW;Mader K .Solid lipid nanoparticles Production,characterization and applications[J].Advanced Drug Delivery Reviews,2001,47:165.
[24] Muller RH;Radtke M;Wissing SA .Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations.[J].Advanced drug delivery reviews,2002(Suppl.1):S131-155.
[25] S. S. Davis .Drug delivery systems[J].Interdisciplinary science reviews: ISR,2000(3):175-183.
[26] Angelova,N;Hunkeler,D .Rationalizing the design of polymeric biomaterials.[J].Trends in Biotechnology,1999(10):409-421.
[27] Lin W;Garnett MC;Schacht E;Davis SS;Illum L .Preparation and in vitro characterization of HSA-mPEG nanoparticles.[J].International Journal of Pharmaceutics,1999(2):161-170.
[28] Jain RA .The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices.[J].Biomaterials,2000(23):2475-2490.
[29] Chirila TV;Rakoczy PE;Garrett KL;Lou X;Constable IJ .The use of synthetic polymers for delivery of therapeutic antisense oligodeoxynucleotides.[J].Biomaterials,2002(2):321-342.
[30] LeeH;Jeong J H;Park T G .A new gene delivery formulation of polyethylenimine /DNA complexes coated with PEG conjugated fusogenic peptide[J].Journal of Controlled Release,2001,76:183.
[31] KaanovAV .Taking polycation gene delivery systems from in vitro to in vivo[J].Pharmaceutical Science & Technology Today,2(09):365.
[32] PoutonCW;Seymour L W .Key issues in non-viral gene delivery[J].Advanced Drug Delivery Reviews,2001,46:187.
[33] Torchilin VP. .Structure and design of polymeric surfactant-based drug delivery systems [Review][J].Journal of Controlled Release: Official Journal of the Controlled Release Society,2001(2/3):137-172.
[34] 吕泽,王身国.高分子包囊药物释放体系[J].功能高分子学报,1997(03):429-435.
[35] 王章阳,廖工铁.毫微粒载体材料的体内外降解及毒性[J].中国药学杂志,1999(02):73.
[36] PaulM;Fessi H;Laatiris A et al.Pentamidine-loade poly D, L-lactide nanoparticles: physicochemical properties and stability work[J].International Journal of Pharmaceutics,1997,159:223.
[37] Jagur-GrodzinskiJ .Biomedical application of functional polymers[J].Reactive and Functional Polymers,1999,39:99.
[38] JonesNA;Hill I R C;Stolnik S et al.Polymer chemical structure is a key determinant of physicochemical and colloidal properties of polymer-DNA complexes for gene delivery[J].Biochimica et Biophysica Acta(BBA)-Gene Structure and Expression,2000,1517:1.
[39] ThurmondK;Huang H;Clark C G et al.Shell crosslinked polymer micelles: stabilized assemblies with great versatility and potential[J].Colloids and Surfaces B:Biointerfaces,1999,16:45.
[40] SafarikI;Safariková M .Magnetic nanoparticles and biosciences[J].Monatshefte Fur Chemie,2002,133:737.
[41] Sun W;Xie C;Wang H;Hu Y .Specific role of polysorbate 80 coating on the targeting of nanoparticles to the brain.[J].Biomaterials,2004(15):3065-3071.
上一张 下一张
上一张 下一张
计量
  • 下载量()
  • 访问量()
文章评分
  • 您的评分:
  • 1
    0%
  • 2
    0%
  • 3
    0%
  • 4
    0%
  • 5
    0%